Home | MyCME | All CME | Blog | Psychlopedia
Multimedia CME
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaWhen should you rely on top-ranked treatment options for acute bipolar mania, and when should you skip down to lower-ranked options? In this brief CME activity, expert Dr Suppes describes guideline recommendations and provides a case illustration. [top]

Strategies for Acute and Maintenance Treatment of Bipolar I Disorder

Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder

Trisha Suppes, MD, PhD

Earlier Diagnosis and Expanded Treatment Options for Patients With Parkinson Disease

Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments

Stuart H. Isaacson, MD

Early Recognition and Treatment of Tardive Dyskinesia in Patients with Mood Disorders and Schizophrenia

Treatment Strategies for Tardive Dyskinesia

Daniel E. Kremens, MD, JD

Earlier Diagnosis of Tardive Dyskinesia

Daniel E. Kremens, MD, JD

FDA-Approved Medications to Treat Tardive Dyskinesia

Joseph P. McEvoy, MD

Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia

Joseph P. McEvoy, MD

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease

Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD

Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation

Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD

Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication

Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

John Lauriello, MD and Diana O. Perkins, MD

Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder

Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents

Melissa P. DelBello, MD, MS

Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients

Manpreet K. Singh, MD, MS

Current and Emerging Treatments to Address Unmet Needs in MDD

Current and Emerging Treatments to Address Unmet Needs in MDD

Michael E. Thase, MD

Parkinson Disease: Current Trends in Treatment and Unmet Needs

Parkinson Disease: Current and Emerging Treatment Strategies

Adolfo Ramirez-Zamora, MD

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

Christoph U. Correll, MD, and John Lauriello, MD

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Epidemiology and Prevention of Tardive Dyskinesia

Christoph U. Correll, MD

​​​​